| scholarly article | Q13442814 |
| P50 | author | Péter Ábrányi-Balogh | Q86940467 |
| Maikel Wijtmans | Q88406952 | ||
| Iwan J P de Esch | Q89095911 | ||
| Albert Kooistra | Q42777811 | ||
| P2093 | author name string | Rob Leurs | |
| Henry F Vischer | |||
| György M Keserű | |||
| Gábor Wágner | |||
| Inna Slynko | |||
| Tamara A M Mocking | |||
| P2860 | cites work | Cloning and functional expression of the human histamine H3 receptor | Q22009916 |
| Activation and allosteric modulation of a muscarinic acetylcholine receptor | Q24308061 | ||
| Structure of the human histamine H1 receptor complex with doxepin | Q24595968 | ||
| Structure and function of an irreversible agonist-β(2) adrenoceptor complex | Q24620291 | ||
| International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors | Q26827568 | ||
| Covalent agonists for studying G protein-coupled receptor activation | Q27684620 | ||
| Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction | Q27860958 | ||
| New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays | Q29615588 | ||
| Ligand-binding architecture of human CB2 cannabinoid receptor: evidence for receptor subtype-specific binding motif and modeling GPCR activation. | Q30373403 | ||
| Synthesis and Characterization of a Bidirectional Photoswitchable Antagonist Toolbox for Real-Time GPCR Photopharmacology. | Q55232052 | ||
| A road map for prioritizing warheads for cysteine targeting covalent inhibitors | Q57482329 | ||
| Development of Covalent Ligand–Receptor Pairs to Study the Binding Properties of Nonpeptidic Neurotensin Receptor 1 Antagonists | Q64030164 | ||
| Development of Covalent Ligands for G Protein-Coupled Receptors: A Case for the Human Adenosine A Receptor | Q64094017 | ||
| Homogeneous, Real-Time NanoBRET Binding Assays for the Histamine H3 and H4 Receptors on Living Cells | Q91699828 | ||
| Bioluminescence Resonance Energy Transfer Based G Protein-Activation Assay to Probe Duration of Antagonism at the Histamine H3 Receptor | Q92316024 | ||
| Development of covalent antagonists for β1- and β2-adrenergic receptors | Q92449348 | ||
| Cloning and characterization of a novel human histamine receptor | Q31963519 | ||
| hCB2 ligand-interaction landscape: cysteine residues critical to biarylpyrazole antagonist binding motif and receptor modulation | Q33733994 | ||
| Structure-Based Design of Reactive Nucleosides for Site-Specific Modification of the A2A Adenosine Receptor | Q34162656 | ||
| Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor | Q34249836 | ||
| Design and pharmacological characterization of VUF14480, a covalent partial agonist that interacts with cysteine 98(3.36) of the human histamine H₄ receptor. | Q34324177 | ||
| Keynote review: histamine H3 receptor antagonists reach out for the clinic | Q34479438 | ||
| The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop | Q34504076 | ||
| Peptide Reactivity of Isothiocyanates--Implications for Skin Allergy | Q36587564 | ||
| Molecular-interaction and signaling profiles of AM3677, a novel covalent agonist selective for the cannabinoid 1 receptor | Q36720905 | ||
| The evolution of histamine H₃ antagonists/inverse agonists | Q37831919 | ||
| Several down, a few to go: histamine H3 receptor ligands making the final push towards the market? | Q37944920 | ||
| New developments around histamine H(3) receptor antagonists/inverse agonists: a patent review (2010 - present). | Q38153063 | ||
| Covalent molecular probes for class A G protein-coupled receptors: advances and applications | Q38414435 | ||
| Role of the Histamine H3 Receptor in the Central Nervous System | Q38992604 | ||
| The European Medicines Agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the Committee for Medicinal Products for Human Use. | Q39267586 | ||
| A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design | Q39411714 | ||
| A covalent antagonist for the human adenosine A2A receptor | Q41763691 | ||
| Boiling water-catalyzed neutral and selective N-Boc deprotection | Q43071151 | ||
| The role of transmembrane helix 5 in agonist binding to the human H3 receptor | Q43964575 | ||
| Nucleic acid related compounds. 116. Nonaqueous diazotization of aminopurine nucleosides. Mechanistic considerations and efficient procedures with tert-butyl nitrite or sodium nitrite | Q44134857 | ||
| Covalent modification of lysine residues by allyl isothiocyanate in physiological conditions: plausible transformation of isothiocyanate from thiol to amine. | Q46122495 | ||
| Expanding the Armory: Predicting and Tuning Covalent Warhead Reactivity | Q48315398 | ||
| Probes for narcotic receptor mediated phenomena. 7. Synthesis and pharmacological properties of irreversible ligands specific for .mu. or .delta. opiate receptors | Q48598431 | ||
| Progress with covalent small-molecule kinase inhibitors | Q50033170 | ||
| Selective Photoaffinity Probe That Enables Assessment of Cannabinoid CB2 Receptor Expression and Ligand Engagement in Human Cells. | Q50116595 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 24 | |
| P577 | publication date | 2019-12-11 | |
| P1433 | published in | Molecules | Q151332 |
| P1476 | title | Covalent Inhibition of the Histamine H3 Receptor | |
| P478 | volume | 24 |
Search more.